The Fraunhofer Institute for Translational Medicine and Pharmacology ITMP works in the areas of drug discovery research, preclinical and clinical model development, and clinical research. Fraunhofer ITMP aims at building a bridge between basic research into disease etiology and the development of medicines by pharmaceutical companies. This includes the development of predictive pharmacological models in order to make the earliest possible statements about the efficacy and safety of drugs, thus detecting aberrations and side effects even before the onset of costly clinical phases and to avoid high failure rates. Fraunhofer ITMP also focuses on the development of biological assay systems, highly automated drug screening (high-throughput screening, high-content screening and virtual screening), the identification of biomarkers for the diagnosis of diseases, the monitoring of preclinical and clinical studies, as well as on pharmacological bioinformatics.
At ScreeningPort, the Hamburg site of Fraunhofer ITMP (ITMP-SP), we conduct Discovery Research with a focus on »Drug Discovery«, »Substance Repurposing« and »Medical Data Science«. ITMP-SP offers the full range of drug discovery services, covering all stages from target validation and small molecule screening to drug candidate selection. We use a variety of technologies to best capture physiological conditions in cells and understand the impact of drug candidates on them. The goal of ITMP-SP is to validate screening hits in physiologically relevant cell systems, to understand disease mechanisms and to identify pathways to new therapeutic concepts. In doing so, we are interested in many different diseases (e. g. infection, immunology, neurology, oncology) and associated molecular pathways and develop test environments for research and industry, including automation solutions. And we are very active in creating knowledge from health and behavioral data using modern IT analysis methods, for example to generate new disease hypotheses, perform predictive and risk analyses, or assess modes of action of therapies, including regulatory ones.
What you will do
- Support the project coordination in the successful implementation of national and international funded projects
- Perform project management office tasks
- Coordinate the funding of an international consortium
- Availability as a contact person and communicate directly with national and international consortium partners
- Perform financial audits after important project phases and prepare audits
- Responsibility for the organization and supervision of events and workshops
What you bring to the table
- Completed commercial or business training or completed studies in business administration or industrial engineering
- Fluent written and spoken German and English
- Ideally experience in the administration of EU funding projects or similar research projects on a national level and knowledge of the business requirements
- Experience working with ERP systems, such as SAP, is an advantage.
- Know-how in agile management (e. g. Scrum) is an advantage.
- You have a structured way of working, communicate proactively and have a collaborative style.
- You face challenges with confidence and maintain a high professional standard in dealing with change and ambiguity
What you can expect
- A position in a vibrant and exciting professional environment fostered by an open culture and spirit of community
- A diverse, international workforce with a dynamic work environment that encourages creativity, innovation and teamwork
- The opportunity to collaborate with a large network of scientists on translational projects
- Professional development opportunities
The weekly working time is 39 hours. The position is initially limited to 2 years and can also be filled in part-time. We value and promote the diversity of our employees' skills and therefore welcome all applications - regardless of age, gender, nationality, ethnic and social origin, religion, ideology, disability, sexual orientation and identity. Severely disabled persons are given preference in the event of equal suitability. Appointment, remuneration and social security benefits based on the public-sector collective wage agreement (TVöD). Additionally Fraunhofer may grant performance-based variable remuneration components.
With its focus on developing key technologies that are vital for the future